Acumen Pharmaceuticals

Developer of monoclonal antibody therapeutics for Alzheimer's disease

placeLivermore, California, United States calendar_todayFounded 1996 groups52 employees language acumenpharm.com

Registered entities

Social engagement

Social engagement: 7.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital225%
Private equity225%
Bank & private debt113%
Other / undisclosed338%

Recent activity

1 Jul 2026
Milestone
anniversary
16 Jun 2026
Partnership
JCR Pharmaceuticals
12 May 2026
Milestone
Coming soon